Navigation Links
Global Pharmaceutical Contract Manufacturing Market to Reach Over $31 Billion by 2012 According to a New Report by Global Industry Analysts, Inc.
Date:10/22/2008

Driven by increased outsourcing from cost-pressured, limited pipeline biotech and pharmaceutical companies, the market for pharmaceutical contract manufacturing is projected to exceed $31 billion by 2012.

San Jose, Calif. (PRWEB) October 22, 2008 -- Global pharma industry faces numerous challenges in the form of increasing competition in generic markets, rising cost of new product development, declining research and development (R&D) productivity, shrinking average patent life, and mounting governmental pressure to reduce drug prices. Given the backdrop of such a competitive landscape, the decisive factors for growth and sustainability are faster new drug development and cost containment with Pharmaceutical Contract Manufacturing (PCM) emerging as a strategic option offering several advantages.

Firstly, outsourcing provides pharma companies the opportunity to avail flexibility, quicker time to market, and lower scale-up costs. Thus, companies will be able to meet growing demand for new drugs and focus on their core competencies. Secondly, outsourcing enables companies to reduce excess capacity in their manufacturing networks and restructure supply chains. Finally, value-added outsourcing services meet the increased demand for specialized manufacturing capabilities in key technical niches (such as lyophilization) and increased demand for back-up sources of supply.

Global market for pharmaceutical contract manufacturing (PCM) is estimated at US$20.4 billion for 2008, as stated by Global Industry Analysts, Inc. United States is the single largest market for PCM with revenues projected to be US$12.8 billion in 2012. In terms of revenues, although North America and Europe are the largest markets, Asia with its immense manufacturing capacity is projected to exhibit robust growth. Exhibiting a CAGR of nearly 16%, Asia-Pacific is expected to emerge as the fastest growing region in the global PCM market. Injectables (Injections, Vials & Intravenous Solutions) represent the fastest growing product segment, and are forecast to record revenues of US$10.6 billion by 2015. Solid Dosage Forms (Tablets & Capsules), the largest segment, is vibrant with a projected market value of US$12.3 billion for 2010.

European and North American pharmaceutical contract manufacturing sector is three tiered. Tier 1 companies offer end-to-end services ranging from clinical trials to commercial manufacturing, logistics, packaging, and marketing assistance. Tier 2 companies provide services ranging from early stage project development to commercial level manufacturing. Tier 3 companies are conventional manufacturing companies, which address the needs of the generic drugs industry. However, contract manufacturing in Europe is dominated by generic drug variants, while in North America branded versions are preferred. In Asia, numerous local players operate in the market. Key global market participants include Althea Technologies, Catalent Pharma Solutions, Dishman Pharmaceuticals and Chemicals Ltd, DSM Pharmaceuticals, HAUPT Pharma AG, Jubilant Organosys, Kemwell Pvt. Ltd., Nipro Corp, NextPharma, Patheon Inc., Penn Pharmaceutical Services Ltd.

"Pharmaceutical Contract Manufacturing: A Global Strategic Business Report" published by Global Industry Analysts, Inc., analyzes the global market with hard-to-find data and analytics for key regional markets such as the United States and Europe, along with rapidly growing markets such as Asia. The report provides a review of market trends and issues, drivers, players, recent developments, mergers, acquisitions, alliances and other strategic industry activities. Analytical estimates and projections are presented in terms of annual revenues in US$ over the years 2000 through 2010. Long-term projections are presented for the years 2011 through 2015.

For more details about this research report, please visit http://www.strategyr.com/Pharmaceutical_Contract_Manufacturing_Market_Report.asp

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of over 60,000 smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Email press @ StrategyR.com
Web Site http://www.strategyr.com

###

Read the full story at http://www.prweb.com/releases/contract_manufacturing/pharmaceuticals/prweb1503304.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. My1Stop.com Takes Commercial Printing Global with International Shipping of Custom Printed Products
2. Western Diet Boosts Global Heart Attack Risk 30%
3. Mars First Confectionery Company to Launch Front-of-Pack Nutrition Labeling Globally
4. Global Intelligence Alliance Strengthens Group Organization and Adds Local Presence, Merges With Asian, German and Dutch Partner Companies
5. Global Pharma Integrates Imperium(TM) to Support Launch Content ROI Initiatives!
6. Elements for a UN Global Framework on Mercury Agreed to
7. Intellect Neurosciences, Inc. Grants to Top Tier Global Pharmaceutical Company an Option to License Certain Alzheimers Patents and Patent Applications
8. Catholic Health Organizations Launch Ministry-Wide Effort to Raise Awareness About Global Climate Change
9. Global Sourcing Strategies for the Pharmaceutical Industry 10th - 11th November, Marriott Princeton, New Jersey USA
10. Alzheimers Foundation of America Encourages Global Action on Awareness Raising
11. Dreamhealer Encourages Global Healing of Those Affected by Disasters or Illness
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Global Pharmaceutical Contract Manufacturing Market to Reach Over $31 Billion by 2012 According to a New Report by Global Industry Analysts, Inc. 
(Date:6/27/2016)... ... ... "FCPX editors can now reveal their media with growing colorful split screen ... - CEO of Pixel Film Studios. , ProSlice Color brings the split screens ... reveal the media of their split screens with growing colorful panels. , ProSlice Color ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... TopConsumerReviews.com recently ... of Eyeglasses . , Millions of individuals in the United States and Canada ... become a way to both correct vision and make a fashion statement. Even celebrities ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned by ... to enhance the health of felines. The formula is all-natural and is made from ... the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract ...
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... addition of the "Structural Electronics 2015-2025: Applications, ... In-Mold Electronics, Smart ... Integrated Photovoltaics Structural electronics involves ... as load-bearing, protective structures, replacing dumb structures such ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016  American Respiratory ... testing company, is now able to perform sophisticated lung assessments in ... Medical Technologies , Inc. Patients are no longer ... to ndd,s EasyOne PRO ® , ARL patients like Jeanne R. ... testing done in the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
Breaking Medicine Technology: